每日全球并购：默克收购SpringWorks进入后期谈判 | 中润光学收购戴斯光电控股权（4/28）

晨哨并购2025-04-28

-每日资讯-1、默克收购SpringWorks进入后期谈判德国默克公司正在与美国SpringWorks Therapeutics就收购事宜进行后期谈判，交易金额约35亿美元。默克有望通过此次收购获得一种新批准的罕见疾病药物，并扩大其癌症治疗产品组合。目前双方正在就每股47美元的价格进行协商，但尚未达成具有法律约束力的协议。此次收购将是默克近年来最大的制药交易之一，旨在推动其癌症治疗业务的发展。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2530288734?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-28 20:36","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2530288734","market":"sh","top_or_hot":-1,"title":"每日全球并购：默克收购SpringWorks进入后期谈判 | 中润光学收购戴斯光电控股权（4/28）","media":"晨哨并购","content":"<div>\n<p>-每日资讯-1、默克收购SpringWorks进入后期谈判德国默克公司正在与美国SpringWorks Therapeutics就收购事宜进行后期谈判，交易金额约35亿美元。默克有望通过此次收购获得一种新批准的罕见疾病药物，并扩大其癌症治疗产品组合。目前双方正在就每股47美元的价格进行协商，但尚未达成具有法律约束力的协议。此次收购将是默克近年来最大的制药交易之一，旨在推动其癌症治疗业务的发展。...</p>\n\n<a href=\"https://finance.sina.com.cn/roll/2025-04-28/doc-ineutqhq5074247.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>每日全球并购：默克收购SpringWorks进入后期谈判 | 中润光学收购戴斯光电控股权（4/28）</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n每日全球并购：默克收购SpringWorks进入后期谈判 | 中润光学收购戴斯光电控股权（4/28）\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-28 20:36 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/roll/2025-04-28/doc-ineutqhq5074247.shtml><strong>晨哨并购</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>-每日资讯-1、默克收购SpringWorks进入后期谈判德国默克公司正在与美国SpringWorks Therapeutics就收购事宜进行后期谈判，交易金额约35亿美元。默克有望通过此次收购获得一种新批准的罕见疾病药物，并扩大其癌症治疗产品组合。目前双方正在就每股47美元的价格进行协商，但尚未达成具有法律约束力的协议。此次收购将是默克近年来最大的制药交易之一，旨在推动其癌症治疗业务的发展。...</p>\n\n<a href=\"https://finance.sina.com.cn/roll/2025-04-28/doc-ineutqhq5074247.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SG9999001440.SGD","symbol_name":"United Global Dividend Equity Fund A SGD Dist","start_time":0,"source_url":"https://finance.sina.com.cn/roll/2025-04-28/doc-ineutqhq5074247.shtml","article_id":"2530288734","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2530288734","pubTimestamp":1745843760,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"-每日资讯-1、默克收购SpringWorks进入后期谈判德国默克公司正在与美国SpringWorks Therapeutics就收购事宜进行后期谈判，交易金额约35亿美元。默克有望通过此次收购获得一种新批准的罕见疾病药物，并扩大其癌症治疗产品组合。此次收购将是默克近年来最大的制药交易之一，旨在推动其癌症治疗业务的发展。SpringWorks于2019年上市，专注于罕见癌症和遗传疾病的药物开发，其疗法Ogsiveo已获美国批准用于治疗硬纤维瘤，基因疾病药物gomez kli也于今年2月获批。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688307":"中润光学","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","SG9999001176.USD":"United Global Healthcare Acc USD","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU0965509010.AUD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (AUDHDG) INC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","LU0234572021.USD":"高盛美国核心股票组合Acc","MRK":"默沙东","LU1116320901.HKD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (HKD) INC","LU1929549753.HKD":"FRANKLIN INCOME \"A\" (HKD) INC","LU0203347892.USD":"SCHRODER ISF QEP GLOBAL ACTIVE VALLUE \"A\" (USD)  INC AV","IE000M9KFDE8.USD":"NEUBERGER BERMAN US LARGE CAP VALUE \"A\" (USD) ACC","LU2361045086.USD":"WELLINGTON US QUALITY GROWTH \"A\" (USD) ACC","BK4534":"瑞士信贷持仓","LU0965509101.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"A\" (SGDHDG) ACC","LU2361044865.SGD":"WELLINGTON US QUALITY GROWTH \"A\" (SGDHDG) ACC","IE00BN8TJ469.HKD":"FTGF CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A\" (HKD) INC","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","SG9999014542.SGD":"United Income Focus Trust Acc SGD","LU1037948897.HKD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (HKD) INC","LU1989772923.USD":"CPR Invest - Climate Action A2 Acc USD-H","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","LU0265550946.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A5\" (USD) INC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","LU1699723380.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"AP\" (USD) ACC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU1934455194.USD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"A\" (USD) ACC","SG9999002232.USD":"Allianz Global High Payout USD","BK4559":"巴菲特持仓","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","LU0238689110.USD":"贝莱德环球动力股票基金","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU1934455277.USD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"AD\" (USD) INC","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","LU0965508806.USD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (USD) INC","BK4007":"制药","LU1941712348.USD":"ALLIANZ PET AND ANIMAL WELLBEING \"AT\" (USD) ACC","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU1069347547.HKD":"AB SICAV I - GLOBAL VALUE PORTFOLIO \"AD\" (HKD) INC","LU0058720904.USD":"联博国际健康护理基金A","SG9999014559.SGD":"United Income Focus Trust Dis SGD","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC"},"translate_title":"Daily Global M&A: Merck's acquisition of SpringWorks enters late negotiations Zhongrun Optical acquires controlling stake in Dyess Optoelectronics (4/28)","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688307":1,"MRK":1},"content_text":"-每日资讯-1、默克收购SpringWorks进入后期谈判德国默克公司正在与美国SpringWorks Therapeutics就收购事宜进行后期谈判，交易金额约35亿美元。默克有望通过此次收购获得一种新批准的罕见疾病药物，并扩大其癌症治疗产品组合。目前双方正在就每股47美元的价格进行协商，但尚未达成具有法律约束力的协议。此次收购将是默克近年来最大的制药交易之一，旨在推动其癌症治疗业务的发展。SpringWorks于2019年上市，专注于罕见癌症和遗传疾病的药物开发，其疗法Ogsiveo已获美国批准用于治疗硬纤维瘤，基因疾病药物gomez kli也于今年2月获批。（智通财经）2、中润光学收购戴斯光电控股权中润光学拟使用自有资金和部分超募资金收购湖南戴斯光电有限公司51%的股权，交易完成后戴斯光电将成为其控股子公司。本次收购所需资金总计15,810.00万元，其中1,690.34万元来自超募资金，其余14,119.66万元通过自有资金及并购贷款支付。（智通财经）3、深科达收购控股子公司少数股权深科达拟以4,737.60万元人民币收购控股子公司深圳线马科技有限公司少数股东周尔清所持16.92%的股权。目前，公司持有线马科技64.00%股权，少数股东周尔清、温丽群、林金明分别持有16.92%、14.04%、5.04%股权，合计36.00%。此次交易完成后，公司将持有线马科技80.92%股权，进一步优化产业资源，提升管理效率与综合竞争力。（智通财经）4、晨鸣纸业收购基金份额晨鸣纸业公告，黄冈科技拟向长江产投基金收购晨鸣黄冈基金39.98%的基金份额，交易对价为人民币4.39亿元。目前，公司通过非全资附属公司湛江晨鸣浆纸有限公司持有晨鸣黄冈基金59.97%的份额。收购完成后，集团将持有晨鸣黄冈基金99.95%的份额，其财务业绩将继续并入集团合并财务报表。（智通财经）5、大中华金融收购Fortune Yi Investment Limited大中华金融公告，其全资附属公司Elite Sonic Limited与卖方葛丽君女士订立协议，以1港元收购目标公司Fortune Yi Investment Limited全部股份。目标公司旗下香港公司主要从事投资控股，其附属中国公司专注于生产及销售香精香料、烟草香精及辅料，拥有先进设施和高产能。集团看好其在烟草香精市场的潜力，认为可借此成为烟草制造商的重要供应商。（智通财经）6、恒丰纸业收购锦丰纸业恒丰纸业披露资产收购草案，计划通过发行股份收购四川锦丰纸业100%股权。锦丰纸业拥有国内领先的特种纸生产线，且布局高透成形纸、无铝衬纸等特种纸生产。此次收购将缓解恒丰纸业产能高负荷运转的问题，突破产能瓶颈，同时解决其西南地区客户运输成本高的劣势。此外，锦丰纸业的无铝衬纸新品生产线符合国际市场需求，收购完成后，恒丰纸业将更好地满足国际大客户要求，提升国际市场份额，加速国际市场布局。（智通财经）7、富智康集团收购廊坊公司股权富智康集团发布公告，深圳富泰宏精密工业有限公司与Execustar International Limited签订股权转让协议，深圳富泰宏将以人民币21.91亿元收购富智康精密电子（廊坊）有限公司62.15%的股权。收购完成后，廊坊将成为深圳富泰宏的直接全资附属公司。深圳富泰宏和廊坊均为富智康集团在中国成立的间接全资附属公司，主要从事移动通信系统、手机、电子专用设备及其他产品的生产制造与销售；Execustar为富智康集团在开曼群岛成立的直接全资附属公司，主要从事投资控股业务。（智通财经）\n\n\n海量资讯、精准解读，尽在新浪财经APP","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"merge","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2530288734","isCrawlerRequest":true}